Venus Remedies has reported results for second ended September 30, 2012.
The company has reported 28.42% rise in its net profit at Rs 15.09 crore for the quarter ended September 30, 2012 as compared to Rs 11.75 crore for the same quarter in the previous year. Total income of the company has increased by 15.29% at Rs 110.81 crore for quarter under review as compared to Rs 96.11 crore for the quarter ended September 30, 2011.
Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.
